FSD Pharma Inc. said it has informed Health Canada of its decision to forfeit the marijuana cultivation and sale licenses of its wholly-owned subsidiary, FV Pharma, Inc., and suspend all activities by FV Pharma within 30 days. Currently, FSD Pharma is in the process of liquidating all FV Pharma assets, including the sale of its cannabis production facility in Cobourg which held licenses to cultivate cannabis in Ontario. FSD Pharma said it is actively working to submit an Investigational New Drug Application or IND to the U.S. Food and Drug Administration or FDA for the use of FSD201 to treat hospitalized COVID-19 patients by down-regulating the over-expressed pro-inflammatory cytokine immune response to SARS-CoV-2 virus infection.
– RTT News 07/31/2020 4:03:08 AM